Shares of Edwards Lifesciences Corp. EW inched 0.73% higher to $72.07 Wednesday, on what proved to be an all-around grim ...
Edwards Lifesciences Co. (NYSE:EW – Free Report) – Investment analysts at Leerink Partnrs lifted their FY2024 earnings per ...
RADNOR, PA / ACCESSWIRE / November 30, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a ...
Edwards Lifesciences' (NYSE:EW) stock is up by 4.0% over the past month. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Specifically, ...
On Wednesday, Edwards Lifesciences Corp (EW) stock saw a modest uptick, ending the day at $72.07 which represents a slight increase of $0.52 or 0.73% from the prior close of $71.55. The stock opened ...
Analysts at Leerink Partnrs upped their FY2026 EPS estimates for shares of Edwards Lifesciences in a research note issued to ...
周一,Piper Sandler重申了对Edwards Lifesciences (NYSE:EW)股票的中性评级,目标价格保持在$70.00。该公司预计Edwards Lifesciences将在12月4日的年度投资者日上重申其2024财年的预期,并首次发布2025财年的指引。这场将在纽约举行的活动预计将包括公司产品管线和市场机会的最新情况。
Analysts have set 12-month price targets for Edwards Lifesciences, revealing an average target of $73.71, a high estimate of ...
Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...
Leerink Partners analyst Mike Kratky maintained a Hold rating on Edwards Lifesciences (EW – Research Report) on November 25 and set a price ...
LONDON--Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London ...